Reliable and Affordable R&D Service for Global Life Science

We Are No. 1 in China for a Reason

About Venturepharm

■ No.1 status of New Drug Applications in China for 8 years - Statistics from SFDA

■ One of the five most promising companies in china - Fortune US

■ Entrepreneur and innovation Award 2004 - British Chamber UK

■ Best CRO in Asia; Competitive Strategy Award 2007 - Frost & Sullivan

■ Winner of 2004 Ten Best Management Elites - Government Organization, China

■ Best Run Join Venture 2003 - Association of JV China

Venturepharm Asia is a global life science leader with a strategic focus on venture capital, merchant banking, CRO, CMO, CSO, compound partnering, and royalty sharing. The group develops an innovative full service plus model to position itself strongly in the life science industry. Currently Venturepharm Asia has more than two thousand employees.

Two flagships from the group are public trade companies listed in HK and US:

■ Venturepharm Lab.(HKSE :8225) www.venturepharm.com

-The First Chinese Research-driven Pharmaceutical Service Company Listed Overseas

■ CBI Group (NASDAQ: CBTE) www.cbi-biotech.com

-The Global Leader in Drug Discovery & Service